Pharmafile Logo
Pharmafocus logo
Advanced Search

Biocair opens new site in Belgium

September 21, 2015
Research and Development, Sales and Marketing Biocair

Biocair is pleased to announce the opening of its new premises in Belgium. The new state of the art facility …

News
Press release

FDA grants Opdivo breakthrough status for kidney cancer

September 18, 2015
Research and Development, Sales and Marketing BMS, Breakthrough Therapy Designation, Bristol-Myers Squibb, FDA, Kidney cancer, immuno-oncology, immunotherapy, nivolumab, opdivo, renal cell carcinoma

The FDA has given Bristol-Myers Squibb’s immuno-oncology drug Opdivo Breakthrough Therapy Designation as a kidney cancer treatment. The FDA’s decision …

News
andygriggphoto

Bedrock Healthcare communications appoints new head of med comms

September 18, 2015
Medical Communications Andy Grigg, Bedrock

Andy Grigg has joined Bedrock Healthcare Communications as head of medical communications.  Grigg joins from Inspired Science where he was practice …

Appointment
digital cloud

Report identifies digital trends in life sciences industry

September 18, 2015
Medical Communications digital, disruptive innovations, disruptive technologies, innovation, life sciences

The life sciences industry will be subject to major disruption from five key trends over the coming years, a report …

News
mobile apps

Number of mobile health apps quadruples in two years

September 18, 2015
Medical Communications apps, clinical trials, communications, digital, mhealth, technology

The number of mobile health applications available to consumers has reached more than 165,000, as the industry for sensors and …

News
BIS

UK second in global innovation index

September 18, 2015
Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo

The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …

News
266812

Jamie McGarvey joins Astellas Pharma communications team

September 18, 2015
Medical Communications Astellas, Astellas Pharma, Jamie McGarvey

Astellas Pharma has appointed Jamie McGarvey as senior manager of employee communications within its corporate affairs department.  McGarvey will be …

Appointment
BioInject

Sandoz opens €150m manufacturing facility

September 18, 2015
Manufacturing and Production Austria, BioInject, Novartis, Sandoz

Sandoz has opened a €150m state-of-the-art biopharmaceutical manufacturing facility in Schaftenau, Austria.  Known as BioInject will result in the creation …

News
AstraZeneca_drug_discovery

AstraZeneca and US Government collaborate to develop new antibiotics

September 17, 2015
Research and Development AstraZeneca, Azactam, BARDA, Department of Health and Human Services, HHHS, avibactam, aztreonam

AstraZeneca has entered into a public-private partnership with the US Department of Health and Human Services to develop drugs to …

News
eugene_van_rensburg-astellas

Astellas Pharma EMEA appoints new chief financial officer

September 17, 2015
Sales and Marketing Astellas, Eugene Van Rensburg

Astellas Pharma Europe, Middle East and Africa has appointed Eugene Van Rensburg to the position of chief financial officer, from …

Appointment
Abraxane

NICE says Celgene’s Abraxane is ‘too expensive for pancreatic cancer’

September 17, 2015
Sales and Marketing Abraxane, Celgene, NICE, Pancreatic cancer

NICE has decided not to recommend Abraxane (nab-paclitaxel) by Celgene in combination with gemcitabine for adults with metastatic pancreatic cancer.In …

News
ABPI

PMPCA rules on multiple pharma code breaches

September 17, 2015
Medical Communications, Sales and Marketing ABPI, ABPI Code, PMCPA, Prescriptions Medicine Code of Practice Authority

The industry’s code of conduct regulator has ruled on several alleged breaches of the ABPI code of pharmaceutical conduct by …

News
avastin_24

Cancer Drugs Fund ‘not sustainable in current form’

September 17, 2015
CDF, Cancer Drugs Fund, Department of Health, NHS England, National Audit Office, Public Accounts Committe, Roche, avastin

The Cancer Drugs Fund has improved access to treatments, although the UK still lags behind other countries despite its ‘unsustainable’ …

News
Amgen

Amgen joins M&A rush with deals for Dezima and Xencor

September 16, 2015
Research and Development, Sales and Marketing Amgen, Cancer, Denzime, Xencor, cardiovascular disease, high cholesterol, inflammation

Amgen has struck deals that could potentially be worth $3.25 billion, to purchase the Dutch firm Dezima and kick-off a …

News
Farydak

NICE rejects Farydak for multiple myeloma

September 16, 2015
Sales and Marketing Farydak, NICE, Novartis, multiple myeloma, panobinostat

NICE has rejected Novartis Farydak in its draft guidance, ruling it out as a treatment for multiple myeloma. Farydak (panobinostat) is …

News
PHE logo

Cancers diagnosed earlier in England, but cases rise

September 16, 2015
Cancer, Jeremy Hunt, Public Health England, cancer diagnosis, public health

The proportion of cancers diagnosed by GPs under the ‘two-week wait’ referral pathway rose, and late diagnoses fell, after the …

News
robert_califf

President Obama nominates Dr Robert Califf as new FDA head

September 16, 2015
Manufacturing and Production, Medical Communications

US President Barack Obama has put forward Dr Robert Califf as the next commissioner of the FDA, according to a …

Appointment
diabetes_injection

Sanofi’s LixiLan meets target in Phase III diabetes trial

September 16, 2015
Research and Development Lantus, LixiLan, Lixisenatide, Lxyumia, Sanofi, diabetes, insulin glargine, metformin, type 2 diabetes

Sanofi’s Phase III clinical trial of its Lixilan treatment has achieved its primary endpoint in patients with type 2 diabetes, …

News
clinical trial

The biggest side-effect of making medicine

September 16, 2015
Research and Development evergreening, intellectual property, patent

International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people …

Feature

R&D firms team up to tackle antibiotic resistance

September 16, 2015
Research and Development AMR, Antibiotics, Jim O'Neill, O'Neill review, antimicrobial resistance, drug development

Two companies at the centre of the UK’s R&D efforts to tackle the growing threat of resistance to antibiotics are expanding …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026